Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
This tag page curates 6 Insider Trading articles that analyze recent share moves, director sales, and investor bets to help you assess risk and make smarter decisions.
364 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
A Qualys director recently sold shares worth about $104,000 in an open-market move. Learn how to interpret insider sa...
A high-profile insider sale at Sonic Automotive sparks questions about executive shareholdings and stock outlook. Thi...
A director quietly sold a notable stake in American Superconductor, prompting questions about what it signals for inv...
Insider moves often raise questions for investors. This piece breaks down what Arteris CEO's stock sale could mean, h...
An insider at Rackspace Technology recently disclosed a significant stock sale. This article explains what that means...
When a major investor's affiliate sells a stake in Coursera, it prompts questions about future growth and risk. This ...
Insider sales in biotech can spark questions about a company’s future. This guide breaks down what to watch, how to r...
Insider trades can reveal more than cash changing hands. Explore how a recent Warby Parker director sold shares, what...
A director sold 3,000 BlackLine shares in an open-market move. Here’s how to interpret that action, what it says abou...
A Capri Holdings director sold a sizable stake in a June 2026 open-market trade, triggering questions about motive an...
A high-profile insider move shines a light on AI-driven demand for Willdan's engineering services. This piece breaks ...